Literature DB >> 10927902

Traumatic trochlear nerve palsy following minor occipital impact--four case reports.

K Hoya1, T Kirino.   

Abstract

Four patients presented with transient trochlear nerve palsy following occipital impact. The impact was slight in all patients, and neuroimaging found no lesions of the nerve. Three patients had delayed onset. Two patients did not complain of diplopia, but were only aware of blurred vision. In such patients, the head tilting test was useful for diagnosis. Minor occipital impact can cause trochlear nerve palsy, which requires careful neurological examinations to identify.

Entities:  

Mesh:

Year:  2000        PMID: 10927902     DOI: 10.2176/nmc.40.358

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Isolated, contralateral trochlear nerve palsy associated with a ruptured right posterior communicating artery aneurysm.

Authors:  Seong Son; Cheol Wan Park; Chan Jong Yoo; Eun Young Kim; Jae Myoung Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

Review 2.  Isolated trochlear nerve palsy with perimesencephalic subarachnoid haemorrhage.

Authors:  Koji Adachi; Kouhei Hironaka; Hisaharu Suzuki; Hideaki Oharazawa
Journal:  BMJ Case Rep       Date:  2012-07-09

3.  Delayed Trochlear Nerve Palsy Following Traumatic Subarachnoid Hemorrhage: Usefulness of High-Resolution Three Dimensional Magnetic Resonance Imaging and Unusual Course of the Nerve.

Authors:  Young San Ko; Hee-Jin Yang; Young-Je Son; Sung Bae Park; Sang Hyung Lee; Yeong Seob Chung
Journal:  Korean J Neurotrauma       Date:  2018-10-31

4.  Ruptured aneurysm in the posterior communicating segment of carotid artery presenting with contralateral oculomotor nerve palsy.

Authors:  Guilherme Finger; Otávio Garcia Martins; William Mazzucco Nesi; Mateus Carvalho Casarin; Leandro Pelegrini de Almeida; Felipe Lourenzon Schiavo; Samir Cezimbra Dos Santos; Marco Antonio Stefani
Journal:  Surg Neurol Int       Date:  2019-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.